The light of the tunnel is now visible, according to health experts, as several promising vaccines against COVID-19 are currently in development or being actively deployed.
The virus, which first began to spread in Wuhan, China almost a year ago, quickly blossomed into a global pandemic that continues to ravage several nations around the world. The United States is not without its COVID issues, as cases continue to spike as we approach the Christmas holiday.
In the UK, the first doses of the vaccine are being deployed in a prioritized manner. For the most part, things are going well, but health experts are now warning that allergy sufferers could find themselves with potentially fatal side effects.
Two people who were jabbed with Pfizer’s recently approved coronavirus vaccine in the UK had to be treated for serious adverse reactions — leading to warnings that those with “significant” allergies may not be able to get it.
The unidentified duo — both staff in the UK’s National Health Service (NHS) — needed treatment for an “anaphylactoid reaction” Tuesday after they were among the first in the world to get the shot.
They both had serious reactions, but recovered after treatment, the NHS said.
The pair both had a history of allergic responses, and each carried an adrenaline shot — sometimes called EpiPens — used to save people from potentially fatal reactions.
President Trump has been touting the American government’s plan to deploy a COVID-19 vaccine, known as Operation Warp Speed, but it still waiting on the FDA’s approval of a vaccine to distribute.
Become an insider!
Sign up for our free email newsletter, and we'll make sure to keep you in the loop.